Leiblich Pharmaceutical

Leiblich Pharmaceutical (ライプリヒ製薬 Raiburihi Seiyaku), also known with its German name Leiblich Medizin, is a Japanese-German company headquartered in Frankfurt. It is the largest shareholder of LeMU, built to hide the existence of IBF.

While officially just a pharmaceutical company, it is involved in researching viral weapons such as Tief Blau, and is also responsible for the outbreak in 2017.

The company is also involved in research into the Curé Virus. Since her infection at age 15, Tsugumi Komachi had been detained for 8 years as a subject of research, and she mentions there was at least one other child with her. Years later, her children Hokuto and Sara were also detained for studying their Curé-Sapiens genes.

When Yoichi Tanaka opposed the company in 2001, he and his wife and daughter were threatened. He was detained in IBF, where he kept working for Leiblich, to protect his family.

Since he's familiar with the Curé Virus, it's possible the dark alley doctor who helped Tsugumi when she was fleeing from Leiblich also used to be an employee.